Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Heteroaryloxy 3-substituted propanamines as serotonin and norepinephrine reuptake inhibitors

Heteroaryloxy 3-substituted propanamines as serotonin and norepinephrine reuptake inhibitors

US Patent 7037932 · Granted May 2, 2006

Estimated economic value: $66,388,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

5-methyl-1,3,4-oxadiazol-2-yl compounds2019
(Thieno[2,3-b][1,5]benzoxazepin-4-yl)piperazin-1-yl compounds as dual activity H2017
6-arylalkylamino-2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agoni2014
6-substituted-2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonists2013
Substituted [(5H-pyrrolo[2,1-c][1,4]benzodiazepin-11-yl)piperazin-1-yl]-2,2-dime2012
2-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-3-phenyl pyrazines as 5-HT7 receptor ant2012
5-HT7 receptor antagonists2011
3-Aminopyrrolidines as inhibitors of monoamine uptake2009
Aminomethyl-azacycle derivatives as inhibitors of monoamine uptake2009
Morpholine derivatives as norepinephrine reuptake inhibitors2009
4-Amino-piperidine derivatives as monoamine uptake inhibitors2009
Pyridinylmorpholine derivatives2009